Forty-four percent of firms with 1,000 to 4,999 workers, and 59% of firms with 5,000 or more workers, say that the use of these medications for weight loss was higher than expected
Requires a prescription
Final regulatory approval is expected after the completion of trials.
The TGA has specifically identified retatrutide as an example of an unapproved peptide product and warns that unapproved therapeutic goods have not been evaluated by the agency for safety, quality, or effectiveness
I really cant comment on why this would happen. As with all medications, if a patient notices a significant change in vision, or any other system, they should contact their prescribing provider
Pregnancy test results: Document the dates and results of any home pregnancy tests you take